Skip to main content
Fig. 3 | BMC Women's Health

Fig. 3

From: Characterization of tumor prognosis and sensitive chemotherapy drugs based on cuproptosis-related gene signature in ovarian cancer

Fig. 3

Validation and application of risk score in ovarian cancer. A, B Univariate analysis (A) and multivariate analysis (B) of the hazard ratios for the risk score. C A nomogram to quantitatively predict survival based on the risk score and clinical parameters. D Calibration curves of the nomogram and receiver operating characteristic (ROC) curves (E) to estimate the accuracy and performance of the predictive nomogram. F Validation of risk score in GSE63885 and TCGA. ***p < 0.001, **p < 0.01. ns means no statistical difference

Back to article page

BMC Women's Health

ISSN: 1472-6874

Contact us